Amarin +4.4% AH on U.S. Vascepa co-promotion deal

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Amarin (AMRN) is partnering with Japan's Kowa Pharmaceuticals to co-promote Vascepa in the U.S.

Kowa's 250 U.S. sales reps will join Amarin's 130 sales reps in selling Vascepa. Kowa will be paid a co-promotion fee based on a percentage of Vascepa's gross margins "that increase during the agreement's term, from the high single digits in 2014 to the low twenty percent levels in 2018, subject to certain adjustments."

The initial deal term runs through 2018.

More on Vascepa